Skip NavigationSkip to Content

Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV

  1. Author:
    Hung, Rachel K Y
    Binns-Roemer,Elizabeth
    Booth, John W
    Hilton, Rachel
    Fox, Julie
    Burns, Fiona
    Harber, Mark
    Ustianowski, Andrew
    Hamzah, Lisa
    Burns, James E
    Clarke, Amanda
    Price, David A
    Kegg, Stephen
    Onyango, Denis
    Santana-Suarez, Beatriz
    Campbell, Lucy
    Bramham, Kate
    Sharpe, Claire C
    Sabin, Caroline A
    Winkler,Cheryl
    Post, Frank A
  2. Author Address

    King 39;s College London, London, UK., Basic Research Laboratory, Frederick National Laboratory for Cancer Research and the National Cancer Institute, Frederick, Maryland, USA., Barts Health NHS Trust, London, UK., Guy 39;s and St Thomas 39; NHS Foundation Trust, London, UK., Royal Free London Hospital NHS Foundation Trust, London, UK., Pennine Acute Hospitals NHS Foundation Trust, Manchester, UK., St George 39;s Hospital NHS Foundation Trust, London, UK., University College London, London, UK., Central and North West London NHS Foundation Trust, London, UK., Brighton and Sussex University Hospital NHS Trust, Brighton, UK., Department of Infectious Disease, Brighton and Sussex Medical School, Brighton, UK., The Newcastle Upon Tyne Hospitals, Newcastle, UK., Lewisham and Greenwich NHS Trust, London, UK., Africa Advocacy Foundation, London, UK., King 39;s College Hospital NHS Foundation Trust, London, UK.,
    1. Year: 2022
    2. Date: Mar
    3. Epub Date: 2021 12 13
  1. Journal: Kidney International Reports
    1. 7
    2. 3
    3. Pages: 465-473
  2. Type of Article: Article
  1. Abstract:

    Sickle cell trait (SCT) has been associated with chronic kidney disease (CKD) in African Americans, although evidence for its impact in Africans and people with HIV is currently lacking. We conducted a cross-sectional study investigating the association between SCT and kidney disease in people of African ancestry with HIV in the UK. The primary outcome was estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2. Secondary outcomes were eGFR < 90 ml/min per 1.73 m2, end-stage kidney disease (ESKD; eGFR < 15 ml/min per 1.73 m2, chronic dialysis, or having received a kidney transplant), proteinuria (protein-to-creatinine ratio >50 mg/mmol), and albuminuria (albumin-to-creatinine ratio >3 mg/mmol). Multivariable logistic regression was used to estimate the associations between SCT and kidney disease outcomes. A total of 2895 participants (mean age 48.1 [SD 10.3], 57.2% female) were included, of whom 335 (11.6%) had SCT and 352 (12.2%) had eGFR < 60 ml/min per 1.73 m2. After adjusting for demographic, HIV, and kidney risk factors including APOL1 high-risk genotype status, individuals with SCT were more likely to have eGFR < 60 ml/min per 1.73 m2 (odds ratio 1.62 [95% CI 1.14-2.32]), eGFR < 90 ml/min per 1.73 m2 (1.50 [1.14-1.97]), and albuminuria (1.50 [1.09-2.05]). Stratified by APOL1 status, significant associations between SCT and GFR < 60 ml/min per 1.73 m2, eGFR < 90 ml/min per 1.73 m2, proteinuria, and albuminuria were observed for those with APOL1 low-risk genotypes. Our results extend previously reported associations between SCT and kidney disease to people with HIV. In people of African ancestry with HIV, these associations were largely restricted to those with APOL1 low-risk genotypes. © 2021 International Society of Nephrology. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.ekir.2021.12.007
  2. PMID: 35257059
  3. PMCID: PMC8897676
  4. PII : S2468-0249(21)01597-7

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel